Safety and efficacy of daclatasvir in the management of patients with chronic hepatitis C
about
Daclatasvir combined with peginterferon-α and ribavirin for the treatment of chronic hepatitis C: a meta-analysisRecommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National GuidelineDaclatasvir-based Treatment Regimens for Hepatitis C Virus Infection: A Systematic Review and Meta-AnalysisEfficacy and Safety of Daclatasvir in Hepatitis C: An Overview.
P2860
Safety and efficacy of daclatasvir in the management of patients with chronic hepatitis C
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Safety and efficacy of daclatasvir in the management of patients with chronic hepatitis C
@ast
Safety and efficacy of daclatasvir in the management of patients with chronic hepatitis C
@en
Safety and efficacy of daclatasvir in the management of patients with chronic hepatitis C
@nl
type
label
Safety and efficacy of daclatasvir in the management of patients with chronic hepatitis C
@ast
Safety and efficacy of daclatasvir in the management of patients with chronic hepatitis C
@en
Safety and efficacy of daclatasvir in the management of patients with chronic hepatitis C
@nl
prefLabel
Safety and efficacy of daclatasvir in the management of patients with chronic hepatitis C
@ast
Safety and efficacy of daclatasvir in the management of patients with chronic hepatitis C
@en
Safety and efficacy of daclatasvir in the management of patients with chronic hepatitis C
@nl
P2093
P2860
P3181
P356
P1476
Safety and efficacy of daclatasvir in the management of patients with chronic hepatitis C
@en
P2093
George Zacharakis
Miltiadis Zissis
Spilios Manolakopoulos
Vassilis Giannakopoulos
P2860
P304
P3181
P356
10.20524/AOG.2016.0041
P407
P577
2016-01-01T00:00:00Z